Esperion Therapeutics
ESPR
#6626
Rank
NZ$1.43 B
Marketcap
NZ$5.56
Share price
0.00%
Change (1 day)
202.88%
Change (1 year)

Earnings for Esperion Therapeutics (ESPR)

Earnings in 2025 (TTM): -NZ$49.04 Million

According to Esperion Therapeutics's latest financial reports the company's current earnings are NZ$0.30 Billion. In 2024 the company made an earning of NZ$13.19 Million, an increase over its 2023 earnings that were of -NZ$0.27 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Esperion Therapeutics from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$49.04 Million-471.55%
2024 NZ$13.19 M-104.99%
2023 -NZ$0.27 Billion-15.03%
2022 -NZ$0.32 Billion-20.61%
2021 -NZ$0.4 Billion84.28%
2020 -NZ$0.22 Billion35.75%
2019 -NZ$0.16 Billion-55.71%
2018 -NZ$0.36 Billion19.57%
2017 -NZ$0.3 Billion125.39%
2016 -NZ$0.14 Billion51.43%
2015 -NZ$86.62 Million36.45%
2014 -NZ$63.48 Million43.55%
2013 -NZ$44.23 Million145.26%
2012 -NZ$18.04 Million
2002 -NZ$51.41 Million-7.81%
2001 -NZ$55.76 Million15.03%
2000 -NZ$48.48 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$18.62 B-38,695.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
NZ$9.06 B-18,892.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-NZ$0.95 Billion 1,855.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-NZ$0.13 Billion 149.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
NZ$0.33 M-100.70%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$0.67 B-1,505.17%๐Ÿ‡บ๐Ÿ‡ธ USA